Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
In a randomized, single-blind, 24-week study, participants assigned to dual therapy of 2 mg weekly of the GLP-1 receptor agonist exenatide (Bydureon, AstraZeneca) and 10 mg daily of the SGLT2 inhibitor dapagliflozin (Farxiga, AstraZeneca) lost more weight than those taking either agent alone or those receiving dapagliflozin and metformin extended-release (Xigduo XL, AstraZeneca) or phentermine/topiramate extended-release (Qsymia, Vivus)
If your symptoms change or get worse while taking Ozempic, reach out to your healthcare provider quickly
To maximize the benefits of Dihexa, we recommend maintaining a healthy lifestyle, including regular exercise, a balanced diet, adequate sleep, and stress management techniques
Sodium-Glucose Co-Transporter 2 (SGLT-2) inhibitors and Glucagon-Like Peptide-1 receptor agonists (GLP-1RAs), which were originally designed for the management of type 2 diabetes, are promising emerging strategies for the management of obesity/overweight
01200-X/asset/1ec2c191-5a64-4856-842f-bfa65a8fabc6/main.assets/gr2.jpg)
US$ 23.42
US$ 23.23
US$ 23.96
